Return to homepagePandemic Pact

Behavioural and social science to close gaps in vaccination coverage

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:6 publications

Grant number: 2010212

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $1,736,721.24

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    Prof. Julie Leask

  • Research Location

    Australia

  • Lead Research Institution

    University of Sydney

  • Research Priority Alignment

    N/A

  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Vaccine/Therapeutic/ treatment hesitancy

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

COVID-19 has cost trillions in economic loss globally and devastated entire nations. The pandemic now has the capacity to be much better controlled with vaccination. But the best vaccines - those against COVID-19 and other diseases - are of no use if the public will not, or cannot, take them. This research will help countries to gather a better understanding of why people don't vaccinate and what to do about it.

6 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Role of civil society organisations in immunisation: A scoping review.

Australian adults' views on influenza vaccination: Implications for communication and service quality from a qualitative study.

Tracking the behavioural and social drivers of adult influenza vaccination: Insights from Australia's first serial survey.

Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review.

Optimization of polysaccharides extraction from Tricholoma mongolicum Imai and their antioxidant and antiproliferative activities.

High-level expression, purification and characterization of active human C1q and tumour necrosis factor-related protein-1 in Escherichia coli.